The biosynthetic origin of psychoactive kavalactones in kava 1 1 1,2 1,2 Tomáš Pluskal , Michael P. Torrens-Spence , Timothy R. Fallon , Andrea De Abreu , 1,2 1,2,* Cindy H. Shi , and Jing-Ke Weng 1 Whitehead Institute for Biomedical Research, 455 Main Street, Cambridge, MA 02142 USA. 2 Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139 USA. * Corresponding author. Email:
[email protected] Kava (Piper methysticum) is an ethnomedicinal shrub native to the Polynesian islands with well-established anxiolytic and analgesic properties. Its main psychoactive principles, kavalactones, form a unique class of polyketides that interact with the human central nervous system through mechanisms distinct from those of conventional psychiatric drugs. However, an unknown biosynthetic machinery and difficulty in chemical synthesis hinder the therapeutic use of kavalactones. In addition, kava contains several chalconoids with reported anti-cancer properties, known as flavokavains. Here, we report de novo elucidation of key components of the kavalactone and flavokavain biosynthetic network, encompassing eight specialized metabolic enzymes. We present the structural basis for the evolutionary development of a pair of paralogous styropyrone synthases that establish the kavalactone scaffold as well as the catalytic mechanism of a regio- and stereo-specific kavalactone reductase that produces a subset of chiral kavalactones. We further demonstrate the feasibility of engineering kavalactone production